Noninvasive assessment of liver disease-measurement of hepatic fibrosis using tissue strain imaging

Clinical Imaging

Volumn 31, Issue 2, 2007, Pages 87-92

  Hotta, Naoki ^a   Ayada, Minoru ^a   Okumura, Akihiko ^a   Tshikawa, Tetsuya ^a   Sato, Ken ^a   Oohashi, Tomohiko ^a   Hijikata, Yasutaka ^a   Murayama, Sayaka ^b   Ido, Makoto ^b   Kakumu, Shinichi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

Hepatic fibrosis; Tissue strain imaging

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; MEDICAL IMAGING; PATIENT TREATMENT; STATISTICAL METHODS; TUMORS;

HEPATIC FIBROSIS; ROUTINE CLINICAL PRACTICE; TISSUE STRAIN IMAGING;

DISEASES;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC HEPATITIS; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE STRAIN IMAGING; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER;

EID: 33847032123     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinimag.2006.11.003     Document Type: Article

References (14)

1. Goto K., Mikami T., Onozuka H., et al. Role of left ventricular regional diastolic abnormalities for global diastolic dysfunction in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 19 7 (2006) 857-864
2. Goebel B., Arnold R., Koletzki E., et al. Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individuals: feasibility, normal values and reproducibility. Int J Cardiovasc Imaging 26 (2006) 1569-1573
3. Thomas L., McKay T., Byth K., et al. Abnormalities of left atrial function after cardioversion: an atrial strain rate study. Heart 93 (2006) 89-95
4. Urheim S., Edvardsen T., Torp H., et al. Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
5. Kawagishi T. TDI application measurements. Toshiba Medical Review 68 (1999) 21-25
6. Abe Y. New cardiovascular applications of Aplio-features and usefulness of TDI-Q. Toshiba Medical Review 27 4 (2003) 29-32
7. Kawamoto M., Mizuguchi T., Katsuramaki T., et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 12 27 (2006) 4325-4330
8. Kazemi F., Kettaneh A., Nkontchou G., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45 2 (2006) 230-235
9. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
10. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 1 (2005) 48-54
11. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 3 (2006) 403-408
12. Colletta C., Smirne C., Fabris C., et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 42 4 (2005) 838-845
13. Morishima C., Morgan T., Everhart J., et al. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology 44 2 (2006) 360-367
14. Fontana R., Sanyal A., Mehta S., et al. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol 101 5 (2006) 983-992